Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0006595101
Mon, 02.05.2022
MediClin AG
Offenburg, 2 May 2022
Group sales for the 1st quarter of 2022 significantly above the previous year's figure
In the 1st quarter of 2022, the continuous improvement in occupancy rates in the rehabilitation clinics, which began in the second half of 2021, continued despite high incidences.
"Although the increase in Group sales over the first quart [ … ]
Wed, 30.03.2022
MediClin AG
Group sales and Group operating result in the second year of Corona above previous year - cautious outlook for year 2022
MEDICLIN presented its figures for the 2021 financial year today. At today's virtual balance sheet press and analyst/investor conference, the Management Board commented on the business development in 2021 and commented on the fu [ … ]
Mon, 28.02.2022
MediClin AG
Disclosure of the preliminary figures for the 2021 financial year - result above expectations thanks to better capacity utilization in the 4th quarter of 2021
In the 2021 financial year, MEDICLIN achieved Group sales of EUR 673.1 mill. (previous year: EUR 659.9 mill.) and a consolidated operating result of EUR 11.6 mill. (previous year: EUR 0.2 mi [ … ]
Tue, 02.11.2021
MediClin AG
Business development to date shows an increasing capacity utilization in the clinics
In the first nine months of 2021, MEDICLIN generated Group sales of EUR 498.1 mill. Sales include EUR 13.7 mill. from benefits under the protective shield to manage the coronavirus pandemic, down from EUR 37.7 mill. in the prior-year period. At operating level, wi [ … ]
Fri, 30.07.2021
MediClin AG
The demand for non-corona-induced medical and therapeutic measures has been increasing since mid-2021
In the first months of 2021 - due to the 3rd wave of the corona pandemic - there was still a low number of referrals from acute clinics and a reluctance to make use of rehabilitation services. This led only to a hesitant increase in occupancy in t [ … ]
Fri, 11.06.2021
MediClin AG
Dr. Joachim Ramming becomes the new CEO of MEDICLIN
In today's meeting, the Supervisory Board of MEDICLIN Aktiengesellschaft (MEDICLIN) has appointed Dr. Joachim Ramming as member of the Management Board of MEDICLIN and as Chairman of the Board. The PhD economist and health economist will succeed Volker Hippler on August 1, 2021, who is resigning [ … ]
Fri, 28.05.2021
MediClin AG
MEDICLIN focuses on patient safety and innovative concepts in rehabilitation
At the Annual General Meeting of MEDICLIN Aktiengesellschaft (MEDICLIN) held on May 26, 2021, Chairman of the Management Board Volker Hippler gave a mixed picture of the situation. After the focus of the health policy and legislative measures aimed at preventing an overlo [ … ]
Mon, 03.05.2021
MediClin AG
The effects of the coronavirus pandemic are burdening the business development in the first quarter of 2021
The economic and social effects of the coronavirus pandemic, i.e. lockdown, increasing capacity utilization in intensive care units, reserved capacities and postponed acute treatments, weighed on the business development of MEDICLIN Aktienge [ … ]
Tue, 12.01.2021
MediClin AG
Offenburg, January 12, 2021
The Board of Management of MEDICLIN will be expanded - Dr. York Dhein will join on April 1st, 2021
In its meeting on January 11, 2021, the Supervisory Board of MEDICLIN Aktiengesellschaft appointed Dr. med. York Dhein as additional member to the Management Board of MEDICLIN AG.
The 54-year-old is a specialist in inter [ … ]
Tue, 03.11.2020
MediClin AG
Offenburg, November 3, 2020
MEDICLIN publishes forecast for fiscal year 2020
Return to normal operations is elementary for the future business performance
The ongoing gradual return to normal operations led to increasing occupancy in the clinics in the third quarter of 2020 and thus to a positive development in sales and earnings. The occupancy [ … ]